This investigation determined the anticancer properties of zerumbone (ZER) on the human T-cell (Jurkat) line using the MTT assay, microscopic evaluations, flow cytometric analyses, and caspase activity estimations. The results showed that ZER is selectively cytotoxic to Jurkat cells in a dose and time-dependent manner with IC 50 of 11.9 ± 0.2, 8.6 ± 0.5 and 5.4 ± 0.4 μg/mL at 24, 48 and 72 hours of treatment, respectively. ZER did not produce an adverse effect on normal human peripheral blood mononuclear cells (PBMC). ZER is not as cytotoxic as doxorubicin, which imposed an inhibitory effect on Jurkat cells with IC 50 of 2.1 ± 0.2, 1.8 ± 0.15, 1.5 ± 0.07 μg/mL after 24, 48 and 72 hours treatment, respectively. ZER significantly (P<0.05) arrested Jurkat cells at the G2/M phase of the cell cycle. The antiproliferative effect of ZER on Jurkat cells was through the apoptotic intrinsic pathway via the activation of caspase˗3 and ˗9. The results showed that ZER can be further developed into a safe chemotherapeutic compound for the treatment of cancers, especially leukemia.
Leukemia is the most common cancer among children [1] . Currently, the most widely used anti-leukemia treatments are chemotherapy, radiotherapy, hormonal and immune therapy, and bone marrow transplantation. Generally, most of these treatments damage healthy cells and tissues with short-to long-term sideeffects. Thus there is need to discover more innocuous therapeutic compounds with minimal side-effects as candidates for the next generation of anti-leukemic drugs [2] .
Zerumbone is a crystalline, monocyclic sesquiterpene that was first isolated in 1956 from the essential oil of rhizomes of edible wild ginger, Zingiber zerumbet (L.) Smith. The structure of the compound was first elucidated in 1960, and later characterized by NMR spectroscopy and X-ray crystallography [3] . ZER was shown to have a range of pharmacological properties including antimicrobial [4] , antipyretic [5] , antispasmodic, anticonvulsant [6] , antiulcer [7] , antioxidant [8] , antidiabetic [9] , antitumor [10] , anticancer [11, 12] , anti-inflammatory [13, 14] , antinociceptive, analgesic [15, 16] , antiallergenic [17] , anti-angiogenic [18] , antiadipogenetic [19] , anti-platelet aggregation, anticoagulant [20] , and hepatoprotective [21] activities at various doses and concentrations. As an antitumor agent, ZER possesses antiproliferative properties to several cancer cell lines including cervical (HeLa) [22] , breast (MCF-7) [23, 24] , colonic (COLO205, LS174T, LS180, and COLO320DM) [6, 25] , hepatic (HepG2) [26, 27] , ovarian (Caov-3 and AS52) [28] , pancreatic (PANC-28, MIA PaCa-2, and AsPC-1) [29] and leucocytic (P-388D1, HL-60, NB4 and CEMss) normal and cancer cell lines [30, 31] .
To date the effect of ZER on T-lymphoblastic leukemia cell line (Jurkat cell) has not been investigated by other researchers. The Jurkat cells, an immortalized line of T lymphocytes originally derived from a 14-year old boy with acute lymphoblastic leukemia, were used to determine the therapeutic value of the compound on leukemia. In this study, the objective was to investigate the antiproliferative and cytotoxic effects of ZER on Jurkat cells. Zerumbone, exhibited significant (P<0.05) inhibitory effects towards Jurkat cells ( Figure 1A ) with IC 50 values of 11.9 ± 0.2, 8.6 ± 0.1 and 5.4 ± 0.2 µg/mL after 24, 48 and 72 hours of treatment, respectively. On the other hand, doxorubicin, as positive control, showed IC 50 s of 2.1 ± 0.2, 1.8 ± 0.15, 1.5 ± 0.3 μg/mL on the Jurkat cells in the same treatment periods ( Figure 1B ). Using the trypan blue exclusion assay, ZER did not show significant (P>0.05) antiproliferative effect towards PBMC after 24, 48 or 72 hours of treatment.
Significant morphological changes were observed in the Jurkat cells after treatment with ZER ( Figure 2 ). The main morphological changes included cell membrane blebbing, and progressive nuclear shrinkage with apoptotic bodies, especially at 72 hours posttreatment. On the contrary, untreated cells did not show morphological change, and remained round in shape, shiny in appearance and confluent throughout the incubation period.
Distinct ultrastructural characteristics typical of apoptosis were also observed in the ZER-treated Jurkat cells. These characteristics include membrane blebbing and hole formation at 24 hours posttreatment, cell shrinkage, increased surface irregularities, cytoplasmic extension, and apoptotic body formation at 48 and 72 hours post-treatment ( Figure 3 ). These observations suggest that the effect of ZER on Jurkat cells is time-dependent.
Early apoptosis was observed after 24 hours of ZER treatment with cells exhibiting bright-green nuclei due to intercalation of AO with the fragmented DNA, while the chromatin condensation appeared as dense green areas. Blebbing and nuclear margination mainly appeared after 48 hours of ZER treatment, indicating moderate apoptosis. The late apoptotic cells showed apoptotic bodies and orange staining as the result of AO binding to denaturated DNA and condensation of chromatin after 72 hours of ZER treatment. However, necrotic cells displayed reddish orange intact nuclei ( Figure 4 ). cells gradually increased significantly (P<0.05) in all groups ( Figure 5 and Table 1 ).
Cell cycle analysis demonstrated that ZER induced significant (P<0.05) depletion in the G1 phase population of Jurkat cells with concomitant increase in cells in the G2/M phase after 24, 48 and 72 hours of treatment, respectively ( Figure 6 and Table 2 ).
There was a significantly (P<0.05) greater number of TUNELpositive Jurkat cells (apoptotic cells) in the ZER-treated group compared with the untreated group (Figure 7 and Table 3 ). The DNA fragmentation and number of apoptotic Jurkat cells in the ZER-treated group increased with time. ZER significantly (P<0.05) caused caspase˗3 and ˗9 to a one to three-fold increase in activity over the control. The increase in activity of these caspases was time-dependent ( Figure 8 and Table  4 ).
Medicinal herbs are among the most commonly used complementary and alternative medicines for cancer treatments, with few side-effects [32] . Although information on the potency of pure compounds derived from the medicinal herb is limited, Zingiber zerumbet is still being used as a folk medicine for various ailments. ZER is one of the major phytochemicals derived from the essential oil of the rhizomes [33] . The effect of this compound on Jurkat cells was not known, but in this investigation, we demonstrated for the first time that ZER has significant (P<0.05) cytotoxic effect on Jurkat cells in a dose and time-dependent manner. However, ZER is not as potent as doxorubicin.
It is critical for an anticancer agent to exhibit high cytotoxicity to cancer cells, but not to normal healthy cells. ZER fits this characteristic, being toxic to Jurkat cells while essentially not adversely affecting normal cells. This observation is consistent with that of a previous study which also showed that ZER inhibits the proliferation of cancer cells, while minimally affecting normal cell proliferation [34] .
The anticancer effect of ZER is suggested to be through its α, β-unsaturated carbonyl group, which effectively removes the intracellular glutathione (GSH) by forming a Michael adduct and raising the intracellular redox potential (E). The net effect of this action is inhibition of proliferation of cancer cells. Since the average E in normal cells is higher than that in cancer cells, it is possible that in normal cells E could not be raised high enough by ZER to stop proliferation, which accounts for its weaker effect [35, 36] . This selective effect of ZER is especially useful in clinical applications when treatment requires repeated and prolonged dosage. Our study showed that the greatest promise for ZER would be in the treatment of leukemia.
Microscopic examination is the gold standard for determination of apoptosis [37] . With this technique the whole process of apoptosis can be observed and evaluated based on reliable morphological criteria [38] . In our study, phase contrast, fluorescence and electron microscopic examination showed that leukemic cells underwent apoptosis upon treatment with ZER. The main morphological changes of treated Jurkat cells included blebbing of the cell membrane, progressive nuclear shrinkage and apoptotic body formation, especially at 72 hours post-treatment. Other morphological changes included nuclear margination, chromatin condensation, and DNA fragmentation. ZER triggered formation of these apoptotic morphological features in Jurkat cells in a timedependent manner.
To determine the cell cycle distribution of Jurkat cells, the ZERtreated cells were subjected to flow cytometry in the annexin-V FITC, cell cycle assay and TUNEL assays. The number of viable Jurkat cells after treatment with ZER decreased with time. The analyses also showed that the anticancer activity of ZER on the Jurkat cell line is via the induction of G2/M cell cycle arrest, which is similar to its effect on the P388D1 and NB4 cell lines [31] . The activation of caspases plays a pivotal role in the apoptosis signaling pathway [39] since caspase˗3 is required for DNA fragmentation and most morphological changes related to apoptosis [40] . Caspase˗3 and ˗9 are involved in the mitochondrial intrinsic pathway [41] . In Jurkat cells, ZER significantly increased caspase˗3 and ˗9 activities. The apoptogenic effect of ZER on Jurkat cells is suggested to occur via the mitochondrial intrinsic pathway through the activation of the mitochondrial-dependent caspase cascade. Thus ZER can be further developed into a safe therapeutic compound for the treatment of leukemia.
Experimental
Cell culture: Human acute T-cell leukemia cell line (Jurkat, J.RT3-T3.5) was purchased from American Type Culture Collection (ATCC) (Maryland, USA). The cells were maintained in RPMI-1640 (ATCC, USA) medium, supplemented with sodium pyruvate (2 mM), 10% heat-inactivated fetal calf serum (FCS) (ATCC, USA), 100 units/mL penicillin, and 100 μg/mL streptomycin (Sigma Aldrich, USA), according to the ATCC protocol, cultured in 75 cm 2 culture flasks (TPP, Switzerland) at 37ºC in a humidified atmosphere of 95% air and 5% CO 2 . Cultures were frequently examined under an inverted microscope (Micros, Austria) for confluency and viability.
ZER extraction:
Pure (99.96%), colorless ZER crystals were prepared from essential oil extracted from fresh Zingiber zerumbet rhizomes by steam-distillation, as described earlier [42] . The ZER crystals were kept in clean glass vials at 4ºC until used.
Cytotoxicity of ZER towards Jurkat cells:
The Jurkat cells were seeded into 96-well microculture plates (TPP, Switzerland) at a concentration of 1 × 10 5 cells/mL and treated with various concentrations of ZER. After incubation for 24, 48 and 72 h at 37ºC in 5% CO 2, MTT solution (Sigma Aldrich, USA) was added, and incubated for an additional 4 h in the dark. Immediately the media were aspirated and the remaining purple formazan were then lysed with MTT solubilization solution (Sigma Aldrich, USA). The assay was performed in triplicate. Subsequently, the optical density (OD) was measured at 570 nm using an ELISA plate reader (Universal Microplate reader) (Biotech, Inc, USA). The IC 50 value was determined from the absorbance versus concentration curve. Finally, the values were compared with those of the known antineoplastic agent, doxorubicin (Sigma Aldrich, USA) and with DMSO (Sigma Aldrich, USA) (0.1%) as negative control.
Cytotoxicity of ZER toward primary blood mononuclear cells (PBMC):
BD vacutainer® (CPT™) was used for the separation of primary lymphocytic cells from whole human blood. About 8 mL fresh blood was collected and mixed well. Immediately after centrifugation, the buffy coat containing lymphocytes was gently aspirated and transferred into a cell culture flask containing RPMI-1640 medium (ATCC, USA) supplemented with 10% heat inactivated fetal calf serum. The flask was incubated at 37ºC in 5% CO 2 . Next day, the cells were treated with ZER for 24, 48 and 72 h. The cells were then harvested and examined for evidence of cytotoxicity using the trypan blue exclusion assay [43] .
Light microscopy:
The Jurkat cells were allowed to grow in a 25 cm 2 cell culture flask until 90% confluency and their viability determined using a hemocytometer. Then, 3 mL of Jurkat cells (5 × 10 4 cells/mL) were plated into each well of a 6-well plate (TPP, Switzerland), treated with 5.39 ± 0.43 µg/mL (IC 50 ) ZER and incubated at 37ºC in 5% CO 2 . The untreated cells were used as negative control. Morphological changes were visualized using a normal inverted microscope (Labomed, USA) at 24, 48 and 72 h post-treatment.
Fluorescence microscopy:
The Jurkat cells were plated at a concentration of 1 × 10 6 cell/mL in a culture flask, treated with ZER and incubated at 37ºC in a 5% CO 2 incubator for 24, 48, and 72 h. At the end of these treatments, the cells were centrifuged and the supernatant discarded. Approximately 10 µL of the cell pellets was stained with 10 μL fluorescent dye mixture containing equal volumes (100 µg/mL) of AO and PI for 2 min. Then approximately 10 μL of freshly stained cell suspension was placed onto a glass slide, covered with a cover slip and examined under a fluorescence microscope (Leica, Japan) with Q-floro software installed.
Scanning electron microscopy:
Jurkat cells (2 × 10 6 cells/mL) treated with ZER were incubated for 24, 48 and 72 h in a 5% CO 2 incubator. Untreated cells at 0 h were used as control. The cells were then centrifuged and the pellets fixed with 4% (v/v) glutaraldehyde in 0.1 M cocodylate buffer for 6 h at 4ºC and washed with 3 changes of sodium cocodylate buffer for 10 min each, and post-fixed in 1% osmium tetraoxide for 2 h at 4ºC. The pellets were then rewashed with 3 changes of sodium cocodylate buffer for 10 min each and dehydrated in ascending acetone concentrations of 35, 50, 75 and 95% for 10 min each, followed by trice in 100% acetone, 15 min each time. Critical point drying was achieved using a drier (CDP 030, Bal-TEC, Switzerland) for 30 min. The cells were then affixed to a metal SEM stub and sputter coated with gold using SEM coating unit (E5100 Polaron, UK). The coated specimens were viewed using a scanning electron microscope (JOEL 64000, Japan).
